JP2009542228A - 定方向進化による触媒作用のために最適化されたキメラジンクフィンガーリコンビナーゼ - Google Patents

定方向進化による触媒作用のために最適化されたキメラジンクフィンガーリコンビナーゼ Download PDF

Info

Publication number
JP2009542228A
JP2009542228A JP2009518632A JP2009518632A JP2009542228A JP 2009542228 A JP2009542228 A JP 2009542228A JP 2009518632 A JP2009518632 A JP 2009518632A JP 2009518632 A JP2009518632 A JP 2009518632A JP 2009542228 A JP2009542228 A JP 2009542228A
Authority
JP
Japan
Prior art keywords
seq
recombinase
sequence
site
chimeric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2009518632A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009542228A5 (enExample
Inventor
バーバス，カルロス・エフ，ザ・サード
ゴードリー，ラッセル・エム
Original Assignee
ザ スクリプス リサーチ インスティテュート
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ザ スクリプス リサーチ インスティテュート filed Critical ザ スクリプス リサーチ インスティテュート
Publication of JP2009542228A publication Critical patent/JP2009542228A/ja
Publication of JP2009542228A5 publication Critical patent/JP2009542228A5/ja
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1082—Preparation or screening gene libraries by chromosomal integration of polynucleotide sequences, HR-, site-specific-recombination, transposons, viral vectors
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/80—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor
    • C07K2319/81—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor containing a Zn-finger domain for DNA binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Diabetes (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
JP2009518632A 2006-07-05 2007-07-05 定方向進化による触媒作用のために最適化されたキメラジンクフィンガーリコンビナーゼ Withdrawn JP2009542228A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81890806P 2006-07-05 2006-07-05
PCT/US2007/072869 WO2008006028A2 (en) 2006-07-05 2007-07-05 Chimeric zinc finger recombinases optimized for catalysis by directed evolution

Publications (2)

Publication Number Publication Date
JP2009542228A true JP2009542228A (ja) 2009-12-03
JP2009542228A5 JP2009542228A5 (enExample) 2010-08-26

Family

ID=38895472

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009518632A Withdrawn JP2009542228A (ja) 2006-07-05 2007-07-05 定方向進化による触媒作用のために最適化されたキメラジンクフィンガーリコンビナーゼ

Country Status (8)

Country Link
US (1) US8685687B2 (enExample)
EP (1) EP2046806A4 (enExample)
JP (1) JP2009542228A (enExample)
KR (1) KR20090031938A (enExample)
CN (1) CN101484462A (enExample)
AU (1) AU2007269048A1 (enExample)
CA (1) CA2667974A1 (enExample)
WO (1) WO2008006028A2 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015097519A (ja) * 2013-11-20 2015-05-28 国立研究開発法人産業技術総合研究所 細菌による機能的外来タンパク質の製造方法
JP2020178703A (ja) * 2012-09-04 2020-11-05 ザ スクリプス リサーチ インスティテュート 標的結合特異性を有するキメラポリペプチド

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2822302A1 (en) 2006-02-13 2007-08-23 Alethia Biotherapeutics Inc. Methods of impairing osteoclast differentiation
US8168181B2 (en) 2006-02-13 2012-05-01 Alethia Biotherapeutics, Inc. Methods of impairing osteoclast differentiation using antibodies that bind siglec-15
MY160435A (en) * 2008-06-12 2017-03-15 Univ Putra Malaysia A novel antiviral peptide against avian influenza virus h9n2
WO2010042894A1 (en) * 2008-10-09 2010-04-15 The Regents Of The University Of California NOVEL NUCLEIC ACID CONSTRUCTS CONTAINING ORTHOGONAL SITE SELECTIVE RECOMBINASES (OSSRs)
GB2467167B (en) * 2009-01-26 2013-09-11 Algentech Sas Gene targeting in plants
NZ598457A (en) 2009-08-03 2014-06-27 Recombinetics Inc Methods and compositions for targeted gene modification
US20130005590A1 (en) * 2011-06-06 2013-01-03 The Regents Of The University Of California Synthetic biology tools
WO2013163628A2 (en) * 2012-04-27 2013-10-31 Duke University Genetic correction of mutated genes
US9738879B2 (en) 2012-04-27 2017-08-22 Duke University Genetic correction of mutated genes
WO2014012165A1 (en) 2012-07-19 2014-01-23 Alethia Biotherapeutics Inc. Anti-siglec-15 antibodies
US10793867B2 (en) * 2013-03-15 2020-10-06 Monsanto Technology, Llc Methods for targeted transgene-integration using custom site-specific DNA recombinases
US9828582B2 (en) 2013-03-19 2017-11-28 Duke University Compositions and methods for the induction and tuning of gene expression
JP7085716B2 (ja) 2013-06-05 2022-06-17 デューク ユニバーシティ Ｒｎａガイド遺伝子編集及び遺伝子調節
CN105765592B (zh) 2013-09-27 2019-12-17 科德克希思公司 用于酶变体的自动筛选的方法、装置和系统
JP6309086B2 (ja) * 2013-09-27 2018-04-11 コデクシス， インコーポレイテッド 構造ベース予測モデリング
AU2015218821B2 (en) * 2014-02-21 2019-01-24 President And Fellows Of Harvard College De novo design of allosteric proteins
WO2016081924A1 (en) 2014-11-20 2016-05-26 Duke University Compositions, systems and methods for cell therapy
EP3256487A4 (en) 2015-02-09 2018-07-18 Duke University Compositions and methods for epigenome editing
CN104789555A (zh) * 2015-04-29 2015-07-22 江南大学 一种基于合成单链dna文库进化基因表达调控元件的方法
CN108138164B (zh) * 2015-08-21 2022-05-10 孟山都技术公司 基因组基因座的增强的重组
JP6905755B2 (ja) 2015-08-25 2021-07-21 デューク ユニバーシティ Ｒｎａガイド型エンドヌクレアーゼを使用してゲノム工学における特異性を改善する組成物および方法
EP4089175A1 (en) 2015-10-13 2022-11-16 Duke University Genome engineering with type i crispr systems in eukaryotic cells
MX2018005377A (es) 2015-11-30 2018-11-09 Univ Duke Dianas terapeuticas para la correccion del gen de la distrofina humana por edicion genica y metodos de uso.
CN106011162A (zh) * 2016-01-27 2016-10-12 浙江大学 大肠杆菌细胞内原位进化目标蛋白质的新方法
WO2017180915A2 (en) 2016-04-13 2017-10-19 Duke University Crispr/cas9-based repressors for silencing gene targets in vivo and methods of use
EP3487523B1 (en) 2016-07-19 2023-09-06 Duke University Therapeutic applications of cpf1-based genome editing
CN111727259B (zh) 2017-12-01 2024-04-19 编码治疗公司 工程化的dna结合蛋白
CN109979591B (zh) * 2019-03-12 2021-01-01 众安信息技术服务有限公司 一种基于图神经网络分析斑块进展因子的方法及装置
CN114174520B (zh) * 2019-05-29 2025-07-08 编码治疗公司 用于选择性基因调节的组合物和方法
US11987791B2 (en) 2019-09-23 2024-05-21 Omega Therapeutics, Inc. Compositions and methods for modulating hepatocyte nuclear factor 4-alpha (HNF4α) gene expression
CN110868598B (zh) * 2019-10-17 2021-06-22 上海交通大学 基于对抗生成网络的视频内容替换方法及系统
TW202132565A (zh) * 2019-11-01 2021-09-01 美商聖加莫治療股份有限公司 Ｇｉｎ重組酶變異體
WO2025006468A2 (en) 2023-06-26 2025-01-02 University Of Hawaii Evolved integrases and methods of using the same for genome editing

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1303930A (zh) * 1999-10-27 2001-07-18 上海博容基因开发有限公司 一种新的多肽——锌指蛋白57和编码这种多肽的多核苷酸
GB0222229D0 (en) * 2002-09-25 2002-10-30 Univ Glasgow Mutant recombinases
CA2562552C (en) * 2004-04-30 2014-03-11 Poetic Genetics, Llc Hybrid recombinases for genome manipulation
WO2006078431A2 (en) * 2004-12-22 2006-07-27 The University Of Iowa Research Foundation Compositions and methods related to modified retroviral vectors for restricted, site specific integration

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020178703A (ja) * 2012-09-04 2020-11-05 ザ スクリプス リサーチ インスティテュート 標的結合特異性を有するキメラポリペプチド
KR20210008437A (ko) * 2012-09-04 2021-01-21 더 스크립스 리서치 인스티튜트 표적화된 바인딩 특이도를 갖는 키메라 폴리펩타이드들
KR102357105B1 (ko) 2012-09-04 2022-02-08 더 스크립스 리서치 인스티튜트 표적화된 바인딩 특이도를 갖는 키메라 폴리펩타이드들
JP7100681B2 (ja) 2012-09-04 2022-07-13 ザ スクリプス リサーチ インスティテュート 標的結合特異性を有するキメラポリペプチド
JP2015097519A (ja) * 2013-11-20 2015-05-28 国立研究開発法人産業技術総合研究所 細菌による機能的外来タンパク質の製造方法

Also Published As

Publication number Publication date
AU2007269048A1 (en) 2008-01-10
WO2008006028A2 (en) 2008-01-10
KR20090031938A (ko) 2009-03-30
US8685687B2 (en) 2014-04-01
EP2046806A2 (en) 2009-04-15
EP2046806A4 (en) 2009-10-21
CA2667974A1 (en) 2008-01-10
WO2008006028A3 (en) 2008-12-24
US20100086532A1 (en) 2010-04-08
CN101484462A (zh) 2009-07-15

Similar Documents

Publication Publication Date Title
US8685687B2 (en) Chimeric zinc finger recombinases optimized for catalysis by directed evolution
AU2019200922B2 (en) Chimeric polypeptides having targeted binding specificity
JP6480647B1 (ja) Ｄｎａが編集された真核細胞を製造する方法、および当該方法に用いられるキット
AU745049B2 (en) DNA-based transposon system for the introduction of nucleic acid into DNA of a cell
JP5033288B2 (ja) ゲノム修飾のための改変リコンビナーゼ
US6632672B2 (en) Methods and compositions for genomic modification
US20130045539A1 (en) Meganuclease recombination system
US20130004946A1 (en) Compositions and Methods for Genetic Manipulation and Monitoring of Cell Lines
KR20080003780A (ko) 부위-특이적 세린 리콤비나제 및 그의 이용 방법
CA2799095A1 (en) Meganuclease variants cleaving a dna target sequence from the dystrophin gene and uses thereof
JP2001523450A (ja) 細胞のｄｎａへの核酸の導入のための核酸転移ベクター
WO1998040510A9 (en) Dna-based transposon system for the introduction of nucleic acid into dna of a cell
JP2013518602A (ja) 部分的に一本鎖のドナー分子による標的化ゲノム改変
CA2405768A1 (en) Self-extinguishing recombinases, nucleic acids encoding them and methods of using the same
US7951927B2 (en) Reconstructed human mariner transposon capable of stable gene transfer into chromosomes in vertebrates
Sauer Chromosome manipulation by Cre‐lox recombination
EP1308516A1 (en) Site-directed recombinase fusion proteins and corresponding polynucleotides, vectors and kits, and their uses for site-directed DNA recombination
WO2004029233A2 (en) Mutant recombinases
Sarkar Directed evolution of an HIV-1 LTR specific recombinase for anti-retroviral therapy-a proof of concept study
JPWO2006041096A1 (ja) 黄色ブドウ球菌バクテリオファージφｍｒ１１由来インテグラーゼ、及びその認識配列を利用した部位特異的遺伝子組換え方法
WO2010028245A2 (en) Altered phic31 integrases having improved efficiency and specificity and methods of using same

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100705

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20100705

A072 Dismissal of procedure [no reply to invitation to correct request for examination]

Free format text: JAPANESE INTERMEDIATE CODE: A073

Effective date: 20120321

A300 Application deemed to be withdrawn because no request for examination was validly filed

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 20120403